Eiji Takeshita Selected Research

Eiji Takeshita Research Topics

Disease

11	Ulcerative Colitis 12/2023 - 01/2021
5	Inflammation (Inflammations) 04/2023 - 01/2016
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2016
4	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2021
3	Fatty Liver 10/2021 - 11/2016
2	Colitis 10/2022 - 01/2016
2	Fibrosis (Cirrhosis) 04/2021 - 11/2017
2	Esophageal and Gastric Varices (Esophageal Varices) 07/2005 - 11/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Appendicitis 12/2023
1	Constipation 11/2023
1	Nocturia 11/2023
1	Chronic Disease (Chronic Diseases) 10/2023
1	Erectile Dysfunction 10/2023
1	Prediabetic State (Prediabetes) 09/2023
1	Chronic Hepatitis C 09/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2023
1	Hepatitis C 09/2023
1	Esophageal Achalasia (Megaesophagus) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Dysmenorrhea (Menstrual Pain) 01/2022
1	Cholangitis 10/2021
1	Glucose Intolerance 10/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Schistosomiasis (Bilharziasis) 01/2020
1	Sclerosing Cholangitis 02/2018
1	Autoimmune Pancreatitis 02/2018
1	Disease Progression 08/2017
1	Alcoholic Fatty Liver 08/2017
1	Gastroesophageal Reflux (GERD) 12/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Infections 12/2008
1	Ascites 12/2008
1	Skin Ulcer 12/2008
1	Fever (Fevers) 12/2008
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2008
1	Vasculitis (Vasculitides) 12/2008
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2006
1	Neoplasms (Cancer) 06/2006
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2004

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 11/2016
2	Serum AlbuminIBA 10/2023 - 01/2021
2	AlbuminsIBA 04/2023 - 01/2022
2	Carbonic Anhydrase IIBA 10/2022 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2017
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021 - 08/2017
1	Protein Kinases (Protein Kinase)IBA 01/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2024
1	Caffeine (No Doz)FDA LinkGeneric 12/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2023
1	Coffee FDA Link 12/2023
1	Vitamin A (Retinol)FDA LinkGeneric 12/2023
1	SteroidsIBA 11/2023
1	GlobulinsIBA 04/2023
1	LipidsIBA 01/2023
1	Mesalamine (Mesalazine)FDA LinkGeneric 10/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2022
1	AntigensIBA 10/2022
1	semaglutideIBA 05/2022
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 05/2022
1	Tobacco Smoke Pollution (Passive Smoking)IBA 04/2022
1	InterleukinsIBA 01/2022
1	Serum GlobulinsIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	AntioxidantsIBA 11/2021
1	16S Ribosomal RNAIBA 10/2021
1	Alanine Transaminase (SGPT)IBA 10/2021
1	EnzymesIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 04/2021
1	BilirubinIBA 02/2021
1	Praziquantel (Biltricide)FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2018
1	Palmitic AcidsIBA 08/2017
1	HDL CholesterolIBA 02/2017
1	Triglycerides (Triacylglycerol)IBA 02/2017
1	Uric Acid (Urate)IBA 02/2017
1	CreatinineIBA 02/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 12/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Bacterial AntigensIBA 01/2016
1	EpitopesIBA 01/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2008
1	InterferonsIBA 12/2008
1	Rituximab (Mabthera)FDA Link 06/2006
1	Branched-Chain Amino AcidsIBA 07/2005

Therapy/Procedure

4	Therapeutics 09/2023 - 11/2004
2	Radiofrequency Ablation 01/2016 - 06/2006
1	Myotomy 01/2023
1	Endoscopes 01/2023
1	Oral Administration 10/2022
1	Injections 12/2008
1	Ligation 11/2004